The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rakhmatullin A.R.

Bashkir State Medical University

Kutlubaev M.A.

Bashkir State Medical University

An analysis of clinical and laboratory characteristics of patients with ischemic stroke and COVID-19

Authors:

Rakhmatullin A.R., Kutlubaev M.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11‑2): 34‑37

DOI: 10.17116/jnevro202212211234

Views: 1658

Downloaded: 19

Download PDF (RU)
Contact the author
Table of contents

AN ANALYSIS OF CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC STROKE AND COVID-19
AN ANALYSIS OF CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC STROKE AND COVID-19

To cite this article:

Rakhmatullin AR, Kutlubaev MA. An analysis of clinical and laboratory characteristics of patients with ischemic stroke and COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11‑2):34‑37. (In Russ.)
https://doi.org/10.17116/jnevro202212211234

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
 
МСФ на ЯМ
Close metadata
Recommended articles:
Cognitive impairment in cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16
Cognitive impairment in patients with arte­rial hype­rtension. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):41-48
Algo­rithms for the diagnosis and treatment of cognitive impairment and dysphagia in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):100-107
Effi­cacy and safety of a new sele­ctive oral factor Xa inhi­bitor amidine hydrochloride for the prevention of thro­mboembolic events in hospitalized patients with COVID-19. Resu­lts of a multicenter, prospective, randomized, controlled study. Journal of Venous Diso­rders. 2024;(2):154-162
Stru­ctural-functional status of cardiovascular and respiratory systems, psychoemotional diso­rders in patients with COVID-19 at the time of hospital discharge. Russian Journal of Preventive Medi­cine. 2024;(5):60-68
Use of systemic steroids in hospitalized patients with COVID-19. Russian Journal of Preventive Medi­cine. 2024;(5):75-80
Life quality of universities’ students during COVID-19 pandemic. Russian Journal of Preventive Medi­cine. 2024;(5):92-96
Features of olfa­ctory impairment connected with trigeminal nerve system. Russian Bulletin of Otorhinolaryngology. 2024;(2):33-39
Pulmonary high-frequency percussion ventilation in a patient with an extremely severe course of a new coro­navirus infe­ction. Russian Journal of Anesthesiology and Reanimatology. 2024;(3):81-86
Effi­cacy and Safety of a New Sele­ctive Oral Factor Xa Inhi­bitor Amidine Hydrochloride for Prevention of Thro­mboembolic Events in Hospitalized Patients with COVID-19: a Multiple-Center Prospective Randomized Controlled Study. Journal of Venous Diso­rders. 2024;(2):154-162

OBJECTIVE

To analyze clinical and laboratory characteristics of patients with ischemic stroke associated with COVID-19.

MATERIAL AND METHODS

A retrospective analysis of all cases of COVID-19, including those complicated with ischemic stroke, admitted to the multispecialty infectious hospital in Ufa (Russia) in 2020, was performed. Multivariate analysis was used to identify the independent predictors of the development of ischemic stroke in patients with COVID-19.

RESULTS

Eleven thousand forty hundred and thirty-two patients were admitted to the multidisciplinary infectious hospital during 2020, 1226 of them also suffered from ischemic stroke. Independent predictors of ischemic stroke in COVID-19 included age and laboratory parameters: increase in number of leucocytes, erythrocytes and platelets, increase of the level of creatinine, glucose, total bilirubin and decrease of the level of total protein, and activated partial thromboplastin time.

CONCLUSION

Elderly people, patients with prominent systemic inflammatory response, which presented with leukocytosis, hypercoagulation, multiorgan failure of different severity and hypoproteinemia, were at higher risk of the development of ischemic stroke in COVID-19.

Keywords:

cerebrovascular disorders
ischemic stroke
COVID-19
predictors
inflammation

Authors:

Rakhmatullin A.R.

Bashkir State Medical University

Kutlubaev M.A.

Bashkir State Medical University

Received:

06.09.2022

Accepted:

20.09.2022

List of references:

  1. Flores-Vega VR, Monroy-Molina JV, Jiménez-Hernández LE, et al. SARS-CoV-2: Evolution and Emergence of New Viral Variants. Viruses. 2022 Mar 22;14(4):653.  https://doi.org/10.3390/v14040653
  2. Kutlubaev MA. Clinical and pathogenetic aspects of nervous system impairments in COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(9):130-136. (In Russ.). https://doi.org/10.17116/jnevro2020120091130
  3. Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022 Apr;269(4):1731-1740. https://doi.org/10.1007/s00415-021-10837-7
  4. Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci. 2022 Jan;43(1):67-79.  https://doi.org/10.1007/s10072-021-05679-0
  5. Hatano S. Experience from a multicenter stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541-553. 
  6. Khayrullin AT, Kutlubaev MA, Rakhmatullin AR, Safuanova GSh. Clinical and laboratory predictors of unfavorable outcome in hemorrhagic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(3-2):17-21. (In Russ.). https://doi.org/10.17116/jnevro202212203217
  7. Rankin J. Cerebral vascular accidents in patients over the age ofp60. II. Prognosis. Scott Med J. 1957 May;2(5):200-215.  https://doi.org/10.1177/003693305700200504

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.